Abstract
The expression levels of the FCRL1 gene, which encodes a human B-cell surface receptor, were compared in healthy individuals and patients with autoimmune diseases. The expression levels were evaluated using DNA dot hybridization on membranes with spotted cDNA samples derived from blood-cell sub-populations of patients with autoimmune diseases. Quantification of the hybridization signals showed that FCRL1 expression in peripheral blood B-lymphocytes of patients with multiple sclerosis, lupus anticoagulants, Takayasu’s arteritis, and von Willebrand disease was significantly higher than in healthy individuals. Monoclonal and polyclonal FCRL1-specific antibodies that enable FCRL1 detection in Western blotting, immunohistochemistry, and flow-cytometry assays were generated. It was found that FCRL1 is expressed on the surfaces of mature CD19+ B-cells. In the tonsils, FCRL1-positive cells were located in the crypt area, i.e., in the mantle zone of secondary lymphoid follicles and among the cells of lymphoid epithelium. FCRL1-positive cells were also found in B-cell follicles of the spleen.
This is a preview of subscription content, access via your institution.
Abbreviations
- FCRL:
-
FcR-like receptor
- MAB:
-
monoclonal antibody
References
LeBien T.W., Tedder T.F. 2008. B lymphocytes: How they develop and function. Blood. 112, 1570–1580.
Dalakas M.C. 2008. B cells as therapeutic targets in autoimmune neurological disorders. Nature Clin. Pract. Neurol. 4, 557–567.
Blank M., Shoenfeld Y. 2007. B cell targeted therapy in autoimmunity. J. Autoimmun. 28, 62–68.
Clark E.A., Lane P.J. 1991. Regulation of human B-cell activation and adhesion. Annu. Rev. Immunol. 9, 97–127.
Batista F.D., Harwood N.E. 2009. The who, how, and where of antigen presentation to B cells. Nature Rev. Immunol. 1, 15–27.
Davis R.S. 2007. Fc receptor-like molecules. Annu. Rev. Immunol. 25, 525–560.
Maltais L.J., Lovering R.C., Taranin A.V., Colonna M., Ravetch J.V., Dalla-Favera R., Burrows P.D., Cooper M.D., Davis R.S. 2006. New nomenclature for Fc receptor-like molecules. Nature Immunol. 7, 431–432.
Mechetina L.V., Najakshin AM., Volkova O.Y., Guselnikov S.V., Faizulin R.Z., Alabyev B.Y., Chikaev N.A., Vinogradova M.S., Taranin A.V. 2002. FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur. J. Immunol. 32, 87–96.
Davis R.S., Li H., Chen C.C., Wang Y.H., Cooper M.D., Burrows P.D. 2002. Definition of an Fc receptor-related gene (FcRX) expressed in human and mouse B cells. Int. Immunol. 14, 1075–1083.
Masir N., Jones M., Pozzobon M., Marafioti T., Volkova O.Y., Mechetina L.V., Hansmann M.L., Natkunam Y., Taranin A.V., Mason D.Y. 2004. Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br. J. Haematol. 127, 335–343.
Facchetti F., Cella M., Festa S., Fremont D.H., Colonna M. 2002. An unusual Fc receptor-related protein expressed in human centroblasts. Proc. Natl. Acad. Sci. U. S. A. 99, 3776–3781.
Guselnikov S.V., Ershova S.A., Mechetina L.V., Najakshin A.M., Volkova O.Y., Alabyev B.Y., Taranin A.V. 2002. A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42, and PECAM-1. Immunogenetics. 54, 87–95.
Davis R.S., Wang Y.H., Kubagawa H., Cooper M.D. 2001. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. U. S. A. 98, 9772–9777.
Hatzivassiliou G., Miller I., Takizawa J., Palanisamy N., Rao P.H., Iida S., Tagawa S., Taniwaki M., Russo J., Neri A., Cattoretti G., Clynes R., Mendelsohn C., Chaganti R.S., Dalla-Favera R. 2001. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 14, 277–289.
Miller I., Hatzivassiliou G., Cattoretti G., Mendelsohn C., Dalla-Favera R. 2002. IRTAs: A new family of immunoglobulinlike receptors differentially expressed in B cells. Blood. 99, 2662–2669.
Davis R.S., Ehrhardt G.R., Leu C.M., Hirano M., Cooper M.D. 2005. An extended family of Fc receptor relatives. Eur. J. Immunol. 35, 674–680.
Ershova S.A., Naiakshin A.M., Mechetina L.V., Peklo M.M., Shevelev A.Ia., Vlasik T.N., Chikaev N.A., Taranin A.V. 2005. Expression patterns of the human and mouse IFGP family genes. Mol. Biol. (Moscow). 39, 776–785.
Polson A.G., Zheng B., Elkins K., Chang W., Du C., Dowd P., Yen L., Tan C., Hongo J.A., Koeppen H., Ebens A. 2006. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int. Immunol. 18, 1363–1373.
Daëron M., Jaeger S., Du Pasquier L., Vivier E. 2008. Immunoreceptor tyrosine-based inhibition motifs: A quest in the past and future. Immunol. Rev. 224, 11–43.
Humphrey M.B., Lanier L.L., Nakamura M.C. 2005. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol. Rev. 208, 50–65.
Newman W.G., Zhang Q., Liu X., Walker E., Ternan H., Owen J., Johnson B., Greer W., Mosher D.P., Maksymowych W.P., Bykerk V.P., Keystone E.C., Amos C.I., Siminovitch K.A. 2006. Rheumatoid arthritis association with the FCRL3-169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum. 54, 3820–3827.
Li F.J., Ding S., Pan J., Shakhmatov M.A., Kashentseva E., Wu J., Li Y., Soong S.J., Chiorazzi N., Davis R.S. 2008. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood. 112, 179–187.
Leu C.M., Davis R.S., Gartland L.A., Fine W.D., Cooper M.D. 2005. FcRH1: An activation coreceptor on human B cells. Blood. 105, 1121–1126.
Du X., Nagata S., Ise T., Stetler-Stevenson M., Pastan I. 2008. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood. 111, 338–343.
Sambrook J., Fritsch E.F., Maniatis T., 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press.
Volkova O.Y., Reshetnikova E.S., Mechetina L.V., Chikaev N.A., Najakshin A.M., Faizulin R.Z., Duzhak T.G., Taranin A.V. 2007. Generation and characterization of monoclonal antibodies specific for human FCRLA. Hybridoma. 26, 78–85.
Baranov K., Volkova O., Chikaev N., Mechetina L., Laktionov P., Najakshin A., Taranin A. 2008. A direct antigen-binding assay for detection of antibodies against native epitopes using alkaline phosphatasetagged proteins. J. Immunol. Methods. 332, 73–81.
Perry M., Whyte A. 1998. Immunology of the tonsils. Immunol. Today. 19, 414–421.
Ravetch J.V., Lanier L.L. 2000. Immune inhibitory receptors. Science. 290, 84–89.
Tefferi A., Nichols W.L. 1997. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis, and treatment. Am. J. Med. 103, 536–540.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © K.O. Baranov, O.Yu. Volkova, L.V. Mechetina, N.A. Chikaev, E.S. Reshetnikova, G.M. Nikulina, A.V. Taranin, A.M. Najakshin, 2012, published in Molekulyarnaya Biologiya, 2012, Vol. 46, No. 3, pp. 500–507.
Rights and permissions
About this article
Cite this article
Baranov, K.O., Volkova, O.Y., Mechetina, L.V. et al. Expression of human B-Cell specific receptor FCRL1 in healthy individuals and in patients with autoimmune diseases. Mol Biol 46, 450–456 (2012). https://doi.org/10.1134/S0026893312020045
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893312020045
Keywords
- B cells
- FCRL family
- autoimmune diseases
- monoclonal antibody
- immunohistochemistry
- flow cytometry